Table 1.
Race/ethnicity |
||||
Variable | Latino | White | Black | P a |
No. (%) of subjects | 97 (11) | 236 (28) | 520 (61) | |
Year entering care | .06 | |||
1999–2001 | 31 (32) | 72 (31) | 209 (40) | |
2002–2005 | 31 (32) | 83 (35) | 169 (33) | |
2006–2009 | 35 (36) | 81 (34) | 142 (27) | |
Median age, years bcd (IQR) | 30 (26–37) | 40 (30–46) | 36 (28–45) | <.001 |
Median year of diagnosis cd (IQR) | 2003 (2001–2006) | 2003 (2000–2006) | 2002 (2000–2005) | .002 |
Time from diagnosis to entry d | .04 | |||
<6 months | 86 (89) | 204 (86) | 418 (80) | |
≥6 months | 11 (11) | 32 (14) | 102 (20) | |
Sex cd | .002 | |||
Male | 74 (76) | 179 (76) | 336 (65) | |
Female | 23 (24) | 57 (24) | 184 (35) | |
Residence bc | .02 | |||
Urban | 51 (52) | 163 (69) | 329 (63) | |
Large rural city/town | 31 (32) | 56 (24) | 151 (29) | |
Small and isolated rural | 15 (16) | 17 (7) | 40 (8) | |
Distance to clinic, km bc | <.001 | |||
<97 (60 miles) | 86 (89) | 163 (69) | 342 (66) | |
≥97 (60 miles) | 11 (11) | 73 (31) | 178 (34) | |
Transmission risk group bcd | <.001 | |||
Heterosexual | 58 (60) | 85 (36) | 279 (54) | |
MSM | 31 (32) | 126 (53) | 154 (30) | |
IDU | 2 (2) | 19 (8) | 60 (11) | |
Other/unknown | 6 (6) | 6 (3) | 27 (5) |
NOTE. Data are no. (%) of patients, unless otherwise indicated. IQR, interquartile range; MSM, men who have sex with men; IDU, injection drug user.
P values reflect Pearson’s χ2 test results among all groups and categories.
Statistically significant difference (P < .05) between Latino and white subjects.
Statistically significant difference (P < .05) between Latino and black subjects.
Statistically significant difference (P < .05) between white and black subjects.